Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CELC · against 1,372 other Healthcare companies
Ranked #1,054 of 1,373 · scores higher than 23% of peers · safety percentile 23
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 20–29, including CELC · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CELC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | Not reported | 0.24× | — | — | 33% |
| BetaLower is better · 1,320 reported | 0.20 | 0.53 | 78% | 33% | |
| Current ratioHigher is better · 1,338 reported | 8.93× | 2.62× | 85% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,050 | 12M USD | 24 | 38 | |
| 1,051 | 116.9B USD | 23 | 47 | |
| 1,052 | 15.4B HKD (≈$2.0B) | 23 | 44 | |
| 1,053 | 154.4B BRL (≈$27.8B) | 23 | 43 | |
| 1,054 | 3.4B USD | 23 | 17 | |
| 1,055 | 4.0B USD | 23 | 56 | |
| 1,056 | 193.1B JPY (≈$1.3B) | 23 | 48 | |
| 1,057 | 2.2B USD | 23 | 36 | |
| 1,058 | 3.9B CNY (≈$543M) | 23 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score